Belvedere Trading LLC Biovie Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
SELL
$2.75 - $5.17 $2,794 - $5,252
-1,016 Reduced 10.31%
8,842 $30,000
Q2 2023

Aug 08, 2023
BUY
$4.09 - $8.29 $28,838 - $58,452
7,051 Added 251.19%
9,858 $42,000
Q1 2023

May 15, 2023
BUY
$4.89 - $10.53 $13,726 - $29,557
2,807 New
2,807 $22,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $68.5M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email